New York, United States, July 13, 2022 (GLOBE NEWSWIRE) — Metagenomics is a molecular tool in genomics that analyses mixed genomic materials extracted from a community of organisms using metagenomics sequencing. Metagenomics allows researchers to study organisms that are difficult to culture in the lab. Because most microorganisms have never been cultured, including most of them. “metagenomic sequencing” refers to a thorough examination of all organisms recovered from the environment.

Microbes in various settings can be identified and quantified using metagenomics sequencing. It’s also an opportunity to research unculturable microorganisms and learn about their biological potential. Advancements in metagenomics sequencing, significant applications of metagenomics in various fields, initiatives and funding from government and private bodies for large-scale sequencing projects, and a decrease in sequencing cost are driving the market growth.

Get a Free Sample Copy of This Report @  https://straitsresearch.com/report/metagenomic-sequencing-market/

Advances in Metagenomic Sequencing to Drive the Global Metagenomic Sequencing Market

Technological advancements have allowed metagenomic sequencing platforms to make significant progress in recent years. Due to various factors such as low input sample concentration requirements, lack of experimental bias in microarrays, and others, DNA sequencing is far more helpful and advantageous than traditional microarrays. The total number of produced sequence reads per run has skyrocketed with the advent of massive parallelization of sequencing reactions.

Experts worldwide are looking for a suitable platform that reduces the number of pre-sequencing steps, ensures authentic sequences with long reads (MB to GB) produced per run, works on a DNA molecule without pre-amplification and has high read accuracy. As a result, scientists are concentrating on creating advanced sequencing platforms. Because DNA sequencing is closely linked to metagenomics research, advancements in this area are expected to contribute to market growth.

Report Scope

Report MetricDetails
Market SizeUSD 5.78 Billion by 2030
CAGR17.5% (2022-2030)
Historical Data2019-2020
Base Year2021
Forecast Period2022-2030
Forecast UnitsValue (USD Billion)
Report CoverageRevenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments CoveredBy Product and Service, By Technology, By Application, By Regions
Geographies CoveredNorth America, Europe, Asia-Pacific, LAME and Rest of the World
Key Companies Profiled/VendorsBGI Genomics Co., Ltd., Oxford Nanopore Technologies Ltd, Eurofins Genomics, Illumina, Inc., Macrogen Inc., Pacific Biosciences of California, Inc., PerkinElmer Inc.,
QIAGEN N.V., Swift Biosciences Inc., Thermo Fisher Scientific Inc.
Key Market OpportunitiesAvailability of Cloud Computing for Data Management
Key Market DriversDevelopment in Metagenomic Sequencing
Significant Applications of Metagenomics in Various Fields

Buy Now Full Report @   https://straitsresearch.com/buy-now/metagenomic-sequencing-market

Availability of Cloud Computing for Data Management to Provide Lucrative Opportunities for the Global Metagenomic Sequencing Market

With increased awareness in developing economies, the demand for metagenomic sequencing technologies has grown in scientific communities worldwide. On the other hand, cloud computing offers a tormenting option for on-demand access to computing resources for metagenomics sequencing. Furthermore, in bioinformatics and computational biology, an essential local alignment search tool (BLAST) on accurate metagenomics data in a cloud environment to assess the viability of metagenomic sequencing methods, BLAST is one of the most acceptable applications. It is assumed to consume the majority of resources in that area. As a result, opportunities such as cloud computing for data management are propelling the global metagenomic sequencing market forward. 

Regional Insights

North America dominated the market. It is estimated to reach an expected value of USD 2,035 million by 2030 at a CAGR of 17%. The United States, Canada, and Mexico are the three major countries studied in North America. Because of its stronghold on deoxyribonucleic acid (DNA) sequencing technologies, the Region accounted for the largest share in the global metagenomic sequencing market, owing to the Region’s continuous improvement, availability, and accessibility of DNA sequencing.

In North America, several international manufacturers of DNA sequencing, platforms, equipment, and technologies are very active. Significant players attempt to introduce affordable DNA sequencing technologies in the North American market. This has given the global metagenomics market in this Region a boost, allowing researchers to dig deeper into the microbial ecology. Furthermore, the North American market has seen significant advancements in the use of metagenomics products and technologies in biotechnology, which are expected to open up new avenues and provide numerous opportunities for market expansion.

The Asia-Pacific region is expected to grow the fastest. With a CAGR of 19%, it will reach USD 1,270 million by 2030. Japan, China, Australia, India, and the rest of Asia-Pacific are all studied in this report. The surge in the focus of healthcare professionals toward drug discovery and growth in the biotechnology industry has given Asia-Pacific tremendous potential for metagenomics growth. Furthermore, the increased availability of novel advanced sequencing technologies across this Region’s countries is expected to contribute to the highest growth rate during the forecast period.

Key Highlights

  • The global metagenomic sequencing market was worth USD 1,355 million in 2021 and is expected to reach USD 5,785 million by 2030, growing at a CAGR of 17.5% during the forecast period (2022–2030).
  • By product and service, the market is categorized into reagents and consumables, instruments, and services. The services segment generated the highest revenue in 2021. It is estimated to reach an expected value of USD 3,830 million by 2030 at a CAGR of 17.6%. The high market growth is attributed to the higher adoption of metagenomic sequencing services and analysis & data interpretation solutions. 
  • By technology, the market is categorized into shotgun metagenomics sequencing, 16S rRNA sequencing, whole-genome sequencing and de novo assembly, and metatranscriptomics. The 16S rRNA sequencing segment led the market in 2021. It is estimated to reach an expected USD 2,300 million by 2030 at a CAGR of 17.6%.
  • By application, the market is classified into drug discovery, ecological and environmental metagenomics, clinical diagnostics, biofuel, and industrial. The drug discovery segment was the largest application segment in the market in 2021. It is estimated to reach an expected value of USD 2,120 million by 2030 at a CAGR of 18.3%. Factors like the development and commercialization of drug discovery for unknown pathogenic organisms are expected to drive the growth of the drug discovery segment in the coming years.

Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/metagenomic-sequencing-market/request-sample

Competitive Analysis

  • BGI Genomics Co., Ltd.
  • Oxford Nanopore Technologies Ltd
  • Eurofins Genomics
  • Illumina, Inc.
  • Macrogen Inc.
  • Pacific Biosciences of California, Inc.
  • PerkinElmer Inc.
  • Swift Biosciences Inc.
  • Thermo Fisher Scientific Inc. 

Global Metagenomic Sequencing Market: Segmentation

By Product and Service

  • Reagents and Consumables
  • Instrument
  • Services 

By Technology 

  • Shotgun Metagenomic Sequencing
  • 16s rRNA Sequencing
  • Whole Genome Sequencing and De Novo Assembly
  • Metatranscriptomics

By Application 

  • Drug Discovery
  • Ecological and Environmental Metagenomics
  • Clinical Diagnostics
  • Biofuel
  • Industrial Applications

By Regions 

  • North America
  • Europe
  • Asia-Pacific


1          Introduction

1.1      Market Definition

1.2      Market Scope

2          Research Methodology

2.1      Primary Research

2.2      Research Methodology

2.3      Assumptions & Exclusions

2.4      Secondary Data Sources

3          Executive Summary

4          Market Overview

4.1      Report Segmentation & Scope

4.2      Value Chain Analysis: Metagenomic Sequencing Market

4.2.1  Vendor Matrix

4.3      Key Market Trends

4.3.1  Drivers

4.3.2  Restraints

4.3.3  Opportunities

4.4      Porter’s Five Forces Analysis

4.4.1  Bargaining Power of Suppliers

4.4.2  Bargaining Power of Buyers

4.4.3  Threat of Substitution

4.4.4  Threat of New Entrants

4.4.5  Competitive Rivalry

4.5      Environment & Regulatory Landscape

4.6      Forecast Factors & Relevance of Impact

4.7      Macro-Economic & Geopolitical Scenario

4.8      Parent Market Overview

4.9      Technology Landscape

4.10   Market Share Analysis

4.11   Potential Venture Analysis

4.12   Regional Price Trends

4.13   Raw Material Trends

4.14   Cost Structure Analysis

4.14.1            Labor Cost

4.14.2            Consumables

4.14.3            Maintenance Cost

4.15   Covid-19 Impact Analysis:

4.15.1            Pre and Post Covid-19 Market Scenario Analysis

4.15.2            Market Recovery Timeline and Challenge

4.15.3            Measures Taken by Top Players

4.15.4            Quarterly Market Revenue and Growth Forecast till 2021        North America        Europe        Asia-Pacific        Central and South America and the Caribbean        The Middle East and Africa

5               Product And Services Overview

5.1      Introduction

5.1.1  Market Size & Forecast (Value & Volume)

5.2      Reagents and Consumables

5.2.1  Market Size & Forecast (Value & Volume)

5.3      Instrument

5.3.1  Market Size & Forecast (Value & Volume)

5.4      Services

5.4.1  Market Size & Forecast (Value & Volume)

6               Technology Overview

6.1      Introduction

6.1.1  Market Size & Forecast (Value & Volume)

6.2      Shotgun Metagenomic Sequencing

6.2.1  Market Size & Forecast (Value & Volume)

6.3      16s rRNA Sequencing

6.3.1  Market Size & Forecast (Value & Volume)

6.4      Whole Genome Sequencing and De Novo Assembly

6.4.1  Market Size & Forecast (Value & Volume)

6.5      Metatranscriptomic

6.5.1  Market Size & Forecast (Value & Volume)

7               Applications Overview

7.1      Introduction

7.1.1  Market Size & Forecast (Value & Volume)

7.2      Drug Discovery

7.2.1  Market Size & Forecast (Value & Volume)

7.3      Ecological and Environmental Metagenomics

7.3.1  Market Size & Forecast (Value & Volume)

7.4      Clinical Diagnostics

7.4.1  Market Size & Forecast (Value & Volume)

7.5      Biofuel

7.5.1  Market Size & Forecast (Value & Volume)

7.6      Industrial Applications

7.6.1  Market Size & Forecast (Value & Volume)

8             Regional Overview

8.1      Introduction

8.1.1  Market Size & Forecast (Value & Volume)

8.2      North America

8.2.1  Economic Overview

8.2.2  Market Scenario

8.2.3  U.S.

8.2.4  Canada

8.2.5  Mexico

8.3      Central and South America and the Caribbean

8.3.1  Economic Overview

8.3.2  Market Scenario

8.3.3  Brazil

8.3.4  Argentina

8.3.5  Colombia

8.3.6  Rest of Central and South America and the Caribbean

8.4      Europe

8.4.1  Economic Overview

8.4.2  Market Scenario

8.4.3  Germany

8.4.4  France

8.4.5  The U.K.

8.4.6  Italy

8.4.7  The Rest Of Europe

8.5      Asia-Pacific (APAC)

8.5.1  Economic Overview

8.5.2  Market Scenario

8.5.3  China

8.5.4  Japan

8.5.5  India

8.5.6  Australia

8.5.7  South Korea

8.5.8  Rest Of APAC

8.6      Middle East

8.6.1  Economic Overview

8.6.2  Market Scenario

8.6.3  South Arabia

8.6.4  The UAE

8.6.5  Qatar

8.6.6  Oman

8.6.7  Turkey

8.6.8  The Rest Of Middle East

8.7      Africa

8.7.1  Economic Overview

8.7.2  Market Scenario

8.7.3  Nigeria

8.7.4  South Africa

8.7.5  The Rest Of Africa

9          Competitive Landscape — Manufacturers & Suppliers

9.1      Competition Dashboard

9.2      Industry Structure

9.3      BGI Genomics Co., Ltd.

9.3.1  Business Overview

9.3.2  Financial Performance

9.3.3  Recent Developments

9.3.4  Portfolio

9.4      Oxford Nanopore Technologies Ltd

9.5      Eurofins Genomics

9.6      Illumina, Inc.

9.7      Macrogen Inc.

9.8      Pacific Biosciences of California, Inc.

9.9      PerkinElmer Inc.

9.10   QIAGEN N.V.

9.11   Swift Biosciences Inc.

9.12   Thermo Fisher Scientific Inc.

10       Conclusion & Recommendation

11       Acronyms & Abbreviations

Table of Content and Figure @ https://straitsresearch.com/report/metagenomic-sequencing-market/toc

Market News

  • In June 2021, Illumina announced an agreement with the Belgian Genetic Centers to evaluate whole-genome sequencing (WGS) for the diagnosis of patients with intellectual disabilities (ID) and developmental disorders (DD).
  • In April 2021 – Illumina announced a partnership with Kartos Therapeutics, Inc. to co-develop a tumor protein (TP53) companion diagnostic (CDx) based on Illumina’s comprehensive genomic profiling content assay, TruSight Oncology. It will expand the TruSight Oncology offerings into hematologic malignancies of illumine
  • In February 2021 – PacBio announced that Children’s Mercy Kansas City increased its investment in highly accurate HiFi sequencing with four new Sequel IIe Systems to add to its two existing Sequel IIe Systems.

News Media

The Tangential Flow Filtration Market to Benefit from the Widescale Adoption of Single-Use Technologies

Molecular Diagnostics Market: Future of Early Disease Detection

North America to Dominate the Long Read Sequencing Market

Have a Look at the Related Research Report    

NGS-based RNA-Sequencing Market: Information by Product and Services (Sample Preparation), Technology (Nanopore), Application (Epigenetics), End-User, and Region — Forecast till 2029

Next-Generation Sequencing Market: Information by Product (Consumables, Platforms), Application (Reproductive Health, Cardiovascular, Others), End-Users, and Region — Forecast till 2029

Long Read Sequencing Market: Information by Technology (Nanopore), Product (Consumable), Application (Cancer), Work Flow (Sequencing), End-User (Clinics), and Region—Forecast till 2029

Botanical Drugs Market : Information by Type (Leaves, Stem/Bark), Form (Tablet, Ointment, Spray, Oral Solution), Application (Pharmaceuticals, Dermatology), and Region — Forecast till 2030

Biological Safety Testing Products and Services Market: Information by Product (Test Kits and Reagents), Test (Endotoxin Test, Adventitious Agent), and Region — Forecast till 2029

Immunotherapy Drugs Market: Information by Type (Monoclonal Antibodies), Therapeutic Area (Cancer), End-User (Hospital), and Region — Forecast till 2029

Biosensors Market: Information by Technology (Thermal, Electrochemical), Application (Medical, Food Toxicity), End-User (Home Healthcare Diagnostics), and Region — Forecast till 2030

About Straits Research Pvt. Ltd.

StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.

Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.

For more information on your target market, please contact us below:

Phone: +1 646 480 7505 (the U.S.)

+91 8087085354 (APAC)

+44 208 068 9665 (the U.K.)

Email: sales@straitsresearch.com

Follow Us: LinkedIn | Facebook | Instagram | Twitter


Source link